aTyr Pharma Inc (LIFE)

3.90 -0.26  -6.25% NASDAQ Feb 25, 20:00 Delayed 2m USD

aTyr Pharma Cash from Investing (TTM):

4.012M for Sept. 30, 2019
View 4,000+ financial data types
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 2014. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 4.012M
June 30, 2019 17.53M
March 31, 2019 22.40M
Dec. 31, 2018 37.17M
Sept. 30, 2018 35.78M
June 30, 2018 -24.71M
March 31, 2018 -20.62M
Dec. 31, 2017 -27.64M
Sept. 30, 2017 -15.50M
June 30, 2017 30.94M
March 31, 2017 23.53M
Dec. 31, 2016 33.53M
Sept. 30, 2016 28.83M
June 30, 2016 29.38M
March 31, 2016 -59.43M
Dec. 31, 2015 -71.99M
Sept. 30, 2015 -73.15M
June 30, 2015 -79.74M
March 31, 2015 5.189M
Dec. 31, 2014 -2.246M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More


Cash from Investing (TTM) Benchmarks

SmileDirectClub Inc --
Aethlon Medical Inc -0.1481M
Seneca Biopharma Inc -0.0017M

Cash from Investing (TTM) Range, Past 5 Years

Minimum -79.74M Jun 2015
Maximum 37.17M Dec 2018
Average -5.500M



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.